InsiderTrades

Form 4 for LXEO Lexeo Therapeutics, Inc.

Accepted 2025-10-17 00:00:00 ET · period of report 2025-10-15 · accession 0002009350-25-000003 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2025-10-17 2025-10-15 LXEO See Tai Sandi Chief Development Off A - Grant $0.00 +10.9K 69.8K +19% $0
M 2025-10-17 2025-10-17 LXEO See Tai Sandi Chief Development Off S - Sale $8.95 -3,888 65.9K -6% -$34.8K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-10-15 A A 10,890 $0.00 69,750 D — —
2 Common Common Stock 2025-10-17 S D 44 $9.56 65,862 D — — (F3) This transaction was executed in multiple trades at prices ranging from $9.53 to $9.59. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. (F4) Includes 49,138 RSUs. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
3 Common Common Stock 2025-10-17 S D 3,844 $8.94 65,906 D — — (F2) This transaction was executed in multiple trades at prices ranging from $8.53 to $9.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.